RemedyMD Promotes Adam Slovik as President and Chief Operating Officer
Salt Lake City, UT, August 06, 2008 --(PR.com)-- RemedyMD® Inc., pioneer in the use of predictive informatics to help improve medical outcomes, today announced the promotion of Adam Slovik to President and Chief Operating Officer.
“Adam has all the tools and talent to succeed in this role,” said Gary Kennedy, RemedyMD chairman and CEO. “We expect that his experience, vision, and, perhaps most importantly, his passion for RemedyMD will help us continue to grow as we establish RemedyMD as a leading provider of software to improve clinical outcomes.”
Adam Slovik joined RemedyMD in 2006 and held various positions in the company including EVP of Sales and Marketing. Prior to joining RemedyMD, Slovik was a consultant to startup CEOs, advising companies on strategy and management. In 1993, Slovik co-founded TenFold Corporation, a provider of applications development and infrastructure technologies, where he held numerous senior management roles. Slovik conceived and created TenFold's patented Universal Application™, platform that enables business analysts to rapidly build and deploy applications. Prior to TenFold, Slovik was a founding member of Oracle Corporation’s Applications Division and served in various technical, architectural and product management roles. A frequent lecturer on entrepreneurship, management, strategies and tactics for growing companies, Slovik is also a guest speaker to entrepreneurship classes at the Haas School of Business at UC Berkeley. Slovik earned a Bachelor of Science from the California Institute of Technology.
“I joined RemedyMD because I saw a tremendous opportunity to solve some of the largest problems facing healthcare today,” said Slovik. “We have invested hundreds of person-years developing solutions that are in full production. RemedyMD’s Investigate platform is the only healthcare software platform that enables end-users to configure data collection forms, aggregate and repurpose data, and do sophisticated analysis enabling clinical outcomes. Our customers have a highly und user personalized solution up and running in days weeks. While our competitors are still gathering requirements, our customers are using our applications and seeing measurable improvements in their healthcare outcomes.”
RemedyMD has proven technology to help providers, pharma/biotech and academic research centers manage patient outcomes. The Investigate portfolio of offerings help physicians and researchers manage programs using real-time end user customizable dashboards. This infrastructure is built on a patented database and ontology architecture that allows end users to add new data to an existing clinical framework and report on these easily and in real time.
About RemedyMD
RemedyMD® is a pioneer in the use of predictive informatics to help healthcare providers, physician scientists, and biomedical researchers to better recognize clinical patterns and make new discoveries that lead to improved medical outcomes.
www.RemedyMD.com
###
“Adam has all the tools and talent to succeed in this role,” said Gary Kennedy, RemedyMD chairman and CEO. “We expect that his experience, vision, and, perhaps most importantly, his passion for RemedyMD will help us continue to grow as we establish RemedyMD as a leading provider of software to improve clinical outcomes.”
Adam Slovik joined RemedyMD in 2006 and held various positions in the company including EVP of Sales and Marketing. Prior to joining RemedyMD, Slovik was a consultant to startup CEOs, advising companies on strategy and management. In 1993, Slovik co-founded TenFold Corporation, a provider of applications development and infrastructure technologies, where he held numerous senior management roles. Slovik conceived and created TenFold's patented Universal Application™, platform that enables business analysts to rapidly build and deploy applications. Prior to TenFold, Slovik was a founding member of Oracle Corporation’s Applications Division and served in various technical, architectural and product management roles. A frequent lecturer on entrepreneurship, management, strategies and tactics for growing companies, Slovik is also a guest speaker to entrepreneurship classes at the Haas School of Business at UC Berkeley. Slovik earned a Bachelor of Science from the California Institute of Technology.
“I joined RemedyMD because I saw a tremendous opportunity to solve some of the largest problems facing healthcare today,” said Slovik. “We have invested hundreds of person-years developing solutions that are in full production. RemedyMD’s Investigate platform is the only healthcare software platform that enables end-users to configure data collection forms, aggregate and repurpose data, and do sophisticated analysis enabling clinical outcomes. Our customers have a highly und user personalized solution up and running in days weeks. While our competitors are still gathering requirements, our customers are using our applications and seeing measurable improvements in their healthcare outcomes.”
RemedyMD has proven technology to help providers, pharma/biotech and academic research centers manage patient outcomes. The Investigate portfolio of offerings help physicians and researchers manage programs using real-time end user customizable dashboards. This infrastructure is built on a patented database and ontology architecture that allows end users to add new data to an existing clinical framework and report on these easily and in real time.
About RemedyMD
RemedyMD® is a pioneer in the use of predictive informatics to help healthcare providers, physician scientists, and biomedical researchers to better recognize clinical patterns and make new discoveries that lead to improved medical outcomes.
www.RemedyMD.com
###
Contact
RemedyMD Inc.
Khaja Zafarullah
8017333300
www.remedymd.com
Khaja Zafarullah
8017333300
www.remedymd.com
Contact
Categories